AI assistant
Sending…
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2016
Nov 4, 2016
32254_dirs_2016-11-04_22e63c58-d540-4935-a5e0-5db7c6272621.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2016-11-02
Reporting Person: JORN DEBORA (EVP, Corp. & Comm'l Dev.)
More from EyePoint Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Investor Presentation
2026
Apr 13
Director's Dealing
2026
Mar 24
Legal Proceedings Report
2026
Mar 20
Regulatory Filings
2026
Mar 4
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Jan 7